Pfizer na Sangamo Dozi Mshiriki wa kwanza katika Awamu ya 3 ya Kutathmini Tathmini ya Hemophilia Tiba ya Jeni

Pfizer na Sangamo Dozi Mshiriki wa kwanza katika Awamu ya 3 ya Kutathmini Tathmini ya Hemophilia Tiba ya Jeni

BusinessWire

Image

Please enable the javascript to submit this form

Inafadhiliwa na ruzuku za elimu kutoka Bayer, BioMarin, CSL Behring, Freeline Therapeutics Limited, Pfizer Inc., Spark Therapeutics, na uniQure, Inc.

SSL muhimu